GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CODX · Sep 30, 2025

Co-Diagnostics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-25-022300General Corporate
Capex intensity64thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

51.66% · OPTIONAL · VALID

Operating cash generation18thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-4061.48% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-77.32% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure73thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

749.73% · OPTIONAL · VALID

Gross margin73thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.gross_margin

81.92% · CORE · VALID

Operating margin27thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.operating_margin

-4824.49% · CORE · VALID

R&D intensity91thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

3082.05% · OPTIONAL · VALID

SBC intensity64thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

344.33% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20257/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20257/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
246.19%
Current
51.66%
Delta
-194.52%
Cash Generation Increased
Previous
-5087.37%
Current
-4061.48%
Delta
1025.88%
Growth Increased
Previous
-93.87%
Current
-77.32%
Delta
16.54%
Inventory Pressure Increased
Previous
665.78%
Current
749.73%
Delta
83.95%
Margin Increased
Previous
80.29%
Current
81.92%
Delta
1.63%
Profitability Increased
Previous
-4946.14%
Current
-4824.49%
Delta
121.65%
R And D Intensity Increased
Previous
2877.33%
Current
3082.05%
Delta
204.72%
Sbc Intensity Decreased
Previous
356.19%
Current
344.33%
Delta
-11.86%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · CODX Fundamental State →Has State · Co-Diagnostics, Inc. →Transitioned To · CODX Fundamental State →Transitioned To · CODX CAPEX_INTENSITY_DECREASED →Transitioned To · CODX CASH_GENERATION_INCREASED →Transitioned To · CODX GROWTH_INCREASED →Transitioned To · CODX INVENTORY_PRESSURE_INCREASED →Transitioned To · CODX MARGIN_INCREASED →Transitioned To · CODX PROFITABILITY_INCREASED →Transitioned To · CODX R_AND_D_INTENSITY_INCREASED →Transitioned To · CODX SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.